Brief: Silo Pharma Issues Update on Milestone Achievements in PTSD Drug Development and New Digital Assets Treasury Program
23/10/2025 13:49
Oct 23 (Reuters) - Silo Pharma Inc SILO.O: SILO PHARMA ISSUES UPDATE ON MILESTONE ACHIEVEMENTS IN PTSD DRUG DEVELOPMENT AND NEW DIGITAL ASSETS TREASURY PROGRAM SILO PHARMA INC - PREPARATION FOR FDA IND APPLICATION TO COMMENCE BEFORE YEAR-END Source text: ID:nGNX6hrXkH Further company coverage: SILO.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Silo Pharma
See all newsBrief: Silo Pharma - Enters Asset Purchase Agreement With Larry King On October 13, 2026 - SEC Filing
Brief: Silo Pharma Enters Asset Purchase Agreement With Norsight Consulting On Oct 1 - SEC Filing
Brief: Silo Pharma Enters Asset Purchase Agreement With Parkview Consulting
Brief: Silo Pharma Selling Shareholders Offer On Resale Basis 1.9 Million Shares Of Silo Pharma Common Stock - SEC Filing
Brief: Silo Pharma Regains Compliance With Nasdaq Minimum Bid Price Requirement